What is Mounjaro (Tirzepatide)?

Mounjaro (tirzepatide) is a weekly injection for adults trying to lose weight. It helps people with a high BMI (body mass index) to lose weight. It contains the active substance tirzepatide. Mounjaro® is also known as Zepbound.

As of November 2023, Mounjaro® has been approved as a weight loss treatment in the UK. It is now available by prescription from LloydsPharmacy Online Doctor.

If prescribed, it is important that Mounjaro® is used in conjunction with healthy lifestyle changes, such as increased physical activity and a reduced calorie diet.

How effective is Mounjaro?

When it comes to weight loss, everyone is different. Some people lose weight faster than others. Mounjaro® can help you lose weight from the first dose, along with a healthy diet and regular exercise.

Clinical studies have shown that, on average, patients lost up to 22.5% of their initial weight on the highest dose of Mounjaro® (15 mg) after 72 weeks. Most adults (91%) can also expect to lose at least 5% of their body weight using Mounjaro®.

“While it is an effective weight loss aid, it is not a miracle drug. It is important that this medication is introduced in conjunction with other lifestyle changes, such as a reduced-calorie diet and exercise.” – Dr. Mitra Dutt

Mounjaro vs other weight loss injections

Mounjaro® weight loss injections are one of several prescription drug weight loss options currently available. Others on the market include Wegovy®, Saxenda®, and Ozempic®. But what is the difference between Mounjaro®, Wegovy®, and Ozempic®?

All three treatments are weekly injections
. Mounjaro® contains the active substance tirzepatide. Wegovy® and Ozempic® have the active substance semaglutide.
Mounjaro® and Wegovy® are mainly used for weight loss. Ozempic® is mainly used for blood sugar regulation in type 2 diabetes.
All three treatments reduce and regulate appetite.

Home Cosmetics